Understanding prostate cancer risk in the use of 5-alpha reductase inhibitors

Author

Teemu Murtola

Peer Reviewers

John Calleary and Jay Fowke

Date of Publication

September 2017

DOI

https://doi.org/10.18591/BJUIK.0006